driven by the PitchBook Platform
Developer of drugs for diseases of the retina. The company develops novel therapeutics for debilitating ophthalmic diseases which can be used for the treatment of wet age-related macular degeneration.
You’re viewing a free company profile from the PitchBook Platform. To explore Odin Biotech Partners’s full profile, request a free trial.
© 2018 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.